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Introduction
The family of ATPases shares a number of proteins with conserved functions and molecular composition (Cross & Muller, 2004) . F-, A-and V-ATPases are true biological rotary engines that work as coupled motors: the F1/A1/V1 is chemically driven (i.e., effecting transduction of mechanical and chemical energy) and the membrane-embedded Fo/Ao/Vo is powered by the energy stored in a transmembrane ion gradient (Kuhlbrandt & Davies, 2016; Stock et al, 1999) . Of these, a specialized group, the ATP synthases, is the major route to ATP synthesis. One of the best characterized members of ATPases is the F1Fo-ATP synthase (F1Fo) of E. coli, mitochondria and chloroplasts. It was demonstrated that both F1 and Fo subunits are required for ATP synthesis (Boyer, 1997) .
Most ATPases harness the free energy of the transmembrane electrochemical proton gradient, ΔμH, but some use a Na + gradient instead (e.g., see (Kaim & Dimroth, 1995) ). Differences in amino acid (AA) composition may govern cation specificities. Double mutation in subunit c of the Fo moiety of the F1Fo of P. modestum causes a switch from Na + -to H + -coupled ATP synthesis (Kaim et al, 1997) . Reconstituted bovine Fo alone, although normally selective for H + in the intact F1Fo complex, could form a K + channel (Miedema et al, 1994) , suggesting that key determinants of ion selectivity could also be conferred by the interaction of Fo with the F1 components.
ATP synthase operates as two rotary stepper generators coupled by a common shaft, the γ subunit (Abrahams et al, 1994; Boyer, 1997; Noji et al, 1997) . The torque that is generated by ion flow through the Fo motor operates against the counter-torque in F1 driven by the energy of ATP hydrolysis. The direction of F1Fo is determined by which torque is larger: that of the driving force of the ion gradient or that produced by the ATP chemical potential. Under physiological conditions, Fo torque exceeds the F1-generated counter-torque at ambient ATP levels, and thus the system proceeds toward ATP synthesis. Although the principal function of the F1Fo is to harness the energy stored in electrochemical ion gradients to make ATP, it can nevertheless run backwards (as an ATP hydrolase) pumping ions in the opposite direction in the absence of the activity of a regulated inhibitory protein. This scenario would occur if, (1) the ATP levels would rise substantially relative to the ion gradient magnitude, or (2) the ion gradient becomes dissipated, as occurs during ischemia.
During ischemia, consuming substantial amounts of ATP at a time when its supply is limited would likely be detrimental in energetically-sensitive cells such as cardiomyocytes and neurons. It is known that Inhibitory Factor-1 (IF1), a small ~12kDa regulatory protein, limits the reversal of F1Fo function, and that during ischemia this helps to prevent excessive (or even futile) ATP consumption by damaged mitochondria to maintain ΔΨm. Opening of an ATP-inhibited mitochondrial K + channel (mKATP), activated either by repetitive short periods of ischemia ("ischemic preconditioning") or by K + channel openers (KCO) such as diazoxide (Dz), serves as a critical link in a cascade of kinases preventing the deleterious effects of opening the mitochondrial permeability transition pore (mPTP), limiting cell damage and death after ischemia (Juhaszova et al, 2008; Juhaszova et al, 2004; Zorov et al, 2009 ). Interestingly, Dz binds to and enhances the inhibitory functions of IF1 (Contessi et al, 2004) suggesting a tendency to preserve ATP during ischemia that may lead to enhanced cell survival and resistance to damage.
While the mechanistic basis of ion-selectivity of various ATP synthases is a matter of considerable interest (Leone et al, 2015) , it is even more intriguing to consider the possible significance for mitochondrial function of the accompanying "non-specific" ion flux via F1Fo. The specificity of F1Fo for H + over other cationic species was found to be extremely high (estimated >10 7 ) (Feniouk et al, 2004) . It can be calculated using the Goldman-Hodgkin-Katz equation (Hille, 2001 ) that for H Given the large electrical force driving K + to the mitochondrial matrix, it would make sense to harness this energy to generate ATP rather than to dissipate ΔµK as heat. Because the activity of the respiratory chain is known to be regulated by intramitochondrial volume controlled by K + influx (Garlid et al, 2003) , the added benefit would be the direct coupling of respiratory chain activity and ΔΨm dissipation (caused by energy utilization/production) to an osmotic signal given by the amount of K + traversing F1Fo to make ATP, facilitating the proportional matching between energy supply and demand. Finally, that part of the proton gradient and energy not being directly dissipated via ATP synthase because of the equivalent movement of charge as K + would then be available to drive K + efflux from mitochondria using the K + /H + exchanger (KHE), thus restoring osmotic balance. These principles are fully compatible with Mitchell's chemiosmotic mechanism (Mitchell, 1961; Nicholls & Ferguson, 2013) .
We investigated the possible existence of a novel, regulated function set for ATP synthase based on the postulated ability to harness energy from K + flux. This would enable K + uniporterlike function and serve to facilitate energy supply-demand matching, while under certain circumstances, also to function as a mKATP. We found that while retaining the high degree of H + -selectivity, the chemo-mechanical efficiency, and the monovalent cation conductance of F1Fo can be increased by certain KCOs and by endogenous pro-survival proteins, Bcl-xL and Mcl-1. This process requires IF1, and is regulated naturally by the concentration of ATP. We also demonstrated its role in protection signaling in intact cardiomyocytes. Figure 1A . In the presence of the protonophore FCCP (to enable charge balance necessary for K + flux and to maintain ΔΨm=0), the K + channel opener (KCO) diazoxide (Dz) significantly enhanced the initial rate of K + flux into PL; this effect was completely blocked both by the Fo inhibitor venturicidin B (Vent), and the mKATP blocker, 5-hydroxydecanoate (5-HD), while it was essentially absent in IF1-depleted F1Fo ( Figure 1B) . In unitary ion channel recordings from lipid-bilayer reconstitution experiments with purified F1Fo, Dz reversed ATP-inhibited ion flux that can be blocked by the Fo inhibitor, Vent, by the mKATP inhibitor, glibenclamide ( Figure 1C ) and by Fo inhibitors oligomycin and N,N'-dicyclohexylcarbodiimide (DCCD; not shown). Considering that similar findings are obtained in conventional mitochondrial membrane reconstitution studies (i.e., without using a purified F1Fo), for the first time we show that the unitary ion currents derived from conventional mKATP preparations, which display the same characteristics as the purified F1Fo complex, can be largely inhibited by Vent ( Figure 1D ) at levels that do not affect sarcolemmal mKATP currents. Unitary currents from purified F1Fo exhibit multiple conductance levels ( Figure 1E ,F) in agreement with single channel behavior of conventional mKATP preparations. This complex behavior may arise from the multiple ion-binding positions on the Fo c-ring, the complete analysis of which is beyond the scope of the present report. A comprehensive literature search regarding the single channel characteristics of conventional mKATP channel preparations reconstituted into lipid bilayers indicates that multiple levels are frequently observed (five distinct peaks/conducting states between 20 pS and 120 pS in symmetric 150 mM K glutamate (Jiang et al, 2006; Nakae et al, 2003) and conductances between 100-275 pS in symmetric 100 mM KCl Mironova et al, 1999) which is largely consistent with the present data.
Results

Potassium
The ion-specificity of the observed unitary currents requires closer examination because mammalian F1Fo is thought to make ATP only by H :1 (comparable to that occurring in cells), so it is reasonable to consider that K + permeation may be contributing as well. Furthermore, the potential contribution of anion permeation cannot be excluded a priori. Because only permeant ions contribute to the net ion-current reversal potential (Erev), this was examined in detail under various conditions to assess the possibility of anion permeation and to interpret the changes in cation permeation activated by KCOs. Since complete substitution of the substantially larger and rather non-permeant Hepes anion for Cl -causes no change in Erev (17.9 ± 0.7 vs 18.6 ± 0.5 mV, respectively, P=ns), we concluded that the impact of Cl -permeation via F1Fo is insignificant compared to cations. Additionally, the current-voltage relationship of purified F1Fo was examined in a pH gradient (pHcis=8.0, pHtrans=7. (EK) was +28 mV, Erev was found to be ~+18 mV indicating that both cations must be permeant and contributing to the total currents observed. In this case, Erev is given by:
R is the molar gas constant F is Faraday's constant T is temperature (°K) P and P are the respective ion perm 
We determined that the baseline values for PH and PK (5.2±0.9 ×10 (Bednarczyk et al, 2005; Dahlem et al, 2004; Grigoriev et al, 1999; Jiang et al, 2006; Mironova et al, 1981; Mironova et al, 2004; Nakae et al, 2003; Zhang et al, 2001) Using an electrophysiological approach, we ruled out the presence of any other cation-selective channel activity in our F1Fo preparations (Figure 1 -figure supplement 2A,B) . It has been suggested that a mitochondrial ROMK potassium channel might act as the pore-forming subunit of a cytoprotective mKATP channel (Foster et al, 2012) . Our immunoblotting with anti-ROMK antibody ruled out ROMK channel contamination of the isolated F1Fo (Figure 1 -figure  supplement 2C ). Figure 2E ). Moreover, this effect seems to be restricted to small cations, since there is no ATP generated by KCO activation of the F1Fo in a comparable gradient of TEA In the following sections, we will measure and quantify the importance of these mechanisms.
We provide additional evidence from experiments in living cells to support the discovery that F1Fo can function as a mKATP. Based on previous work by our group (Juhaszova et al, 2004; Juhaszova et al, 2009 ) as well as by others (Garlid et al, 2003; Halestrap, 1989; Sato et al, 1998) the following reveal key manifestations of mKATP activation in cardiomyocytes in response to KCOs: (1) flavoprotein (FP) oxidation, (2) modulation of mitochondrial regulatory swelling (i.e., due to mitochondrial K + accumulation), (3) volume activation of respiration (as a consequence of #2), (4) inhibition of GSK-3β activity via ser-9 phosphorylation, and (5) increased mPTP reactive oxygen species (ROS)-threshold. We examined each one of these manifestations of mKATP activation by Dz in myocytes with IF1 knocked down by ~75% through gene silencing ( Figure 3A -C), compared to cells treated with control siRNA ( Figure 3A ,B). Additionally, Dz produced an equivalent increase in FP oxidation in control myocytes ( Figure 3D ) as compared to a blunted FP KCO-driven activation of mKATP causes mitochondrial swelling (Garlid et al, 2003) which in turn increases respiration (Halestrap, 1989; Korge et al, 2005) . Using a novel single cardiac myocyte imaging technique (Juhaszova et al, 2004) , we have found that KCO Dz, HOE694 (HOE; NHE-1 inhibitor), and the δ-opioid peptide, DADLE, each cause a rapid ~2.5-4% increase in the average volume of mitochondria throughout the cardiomyocyte and increase in respiration (Figure 4A-C;G). In cardiac myocyte suspension, we found that pharmacologic agents that cause mitochondrial swelling (Dz, HOE, and DADLE) increased oxygen consumption (VO2) over baseline by about 10%, 25-30%, and 35%, respectively, when utilizing glucose, the medium-and long-chain fatty acid octanoate or palmitate, respectively, and that by preventing this volume increase (e.g., using the Cl -channel inhibitor, IAA-94) the accompanying increase in respiration was similarly eliminated (Juhaszova et al, 2004) . Thus, volume activation of respiration is a direct correlate of mitochondrial regulatory volume swelling. Using the same logic as the preceding section, since DADLE causes similar and rapid increases in respiration (as Dz) but is known to not activate the mKATP, it was employed as a negative control in the next series of experiments. We found that Vent completely prevented the Dz-related increase in cardiomyocyte swelling and respiration ( Figures 4D,G) , while the actions of HOE or DADLE were unaffected ( Figures 4E-G) . Thus, only the specific effect of Dz acting through the mKATP to cause mitochondrial swelling leading to an increase in respiration, but not that of DADLE, requires the function of Fo.
Effects on mPTP ROS-threshold
The mPTP is a key end-effector of protection signaling: the threshold for mPTP-induction by ROS being significantly reduced after ischemia-reperfusion injury and contributing to cell death, but beneficially increased by preconditioning, postconditioning and other forms of protection signaling, contributing to cell survival (Juhaszova et al, 2004; Juhaszova et al, 2009) . We showed that cell protection involves convergence of a multiplicity of potential and distinct upstream pathways (including opening of mKATP), each acting via inhibition of GSK-3β on the end effector, the mPTP complex, to limit its induction (see Figure 4H -K). The activity of GSK-3β is inversely related to the phosphorylation status of serine (Ser)-9. Dephosphorylation of this site, or mutations that prevent phosphorylation, result in activation of the kinase (Antos et al, 2002) . We found that constitutive activation of GSK-3β prevents the ability to engage protective signaling in cardiomyocytes through pathways including PKA, PKB, PKC, PKG and p70s6K. We also found that Dz (as well as numerous other distinct protection-signaling triggers (Juhaszova et al, 2004) ), resulted in GSK-3β phosphorylation on regulatory serine-9 (including the fraction isolated from mitochondrial membranes). Thus, in the present experiments we compared the ability of Dz to phosphorylate GSK-3β on regulatory Ser-9 in cardiomyocytes with IF1-expression knocked down by ~75% through siRNA, compared to controls. While Dz causes a significant increase in P-GSK-3β in control cells, this was largely prevented in IF1-siRNA treated cells ( Figure 4H ). We conclude that mKATP-related protection signaling via GSK-3β requires the functional presence of IF1, thus implicating the role of the F1Fo. Further support for this role comes from the ability of Vent to similarly block phosphorylation of GSK-3β by Dz.
We have found that Dz, HOE, Li + (a direct pharmacologic inhibitor of GSK-3β), and insulin, each cause a significant increase of the ROS-threshold for mPTP induction, t MPT (Juhaszova et al, 2004) (Figures 4I-L) . Since HOE, Li + and insulin each cause protection via mKATP-independent mechanisms they were employed as negative controls in the next series of experiments. The degree of protection (i.e., prolonged t MPT ) afforded by HOE, Li + , and insulin was largely unaffected by IF1-knockdown ( Figure 4H ,J,K). In stark contrast, the effect of Dz was decreased in direct relation to the degree of IF1-knockdown, i.e., t MPT -increase was reduced by about half with ~50% IF1-knockdown, and completely abolished with ~75% IF1-knockdown ( Figure 4H,J) . We conclude that mKATP-related protection signaling to the mPTP requires the functional presence of IF1, thus implicating the role of ATP synthase. This is compatible with a recently demonstrated role of IF1 in cytoprotection (Campanella et al, 2008; Formentini et al, 2012) . Furthermore, similarly to IF1-knockdown, Vent blocked the protection by Dz ( Figure 4L ). However, while blockage of Fo by Vent prevents mKATP (Dz)-mediated cardioprotection, it does not do so in the case of DADLE or HOE.
Regulation of F 1 F o by Bcl-xL and Mcl-1
Suspecting that the effect of Dz and pinacidil via IF1 could be naturally operating under the control of yet-to-be discovered endogenous ligands of IF1 we set out to find them. We examined IF1 for conserved survival protein-related homology domains since IF1 is known to have a "minimal inhibitory domain" sequence of 33 amino acids that binds to the β-subunit of F1 (Gledhill et al, 2007) . We found that IF1 contains a conserved BH3-like domain (residues 32-46) that significantly overlaps its minimal inhibitory sequence (residues 14-47) ( Figure 5A ), and that BclxL ( Figure 5B ,D) and Mcl-1 ( Figure 5D ), which are each known to have a BH3-binding groove, exert effects comparable to Dz on the H + and K + ion currents sustained by ATP synthase ( Figures  5B-D) . Furthermore, the effect of Bcl-xL and remarkably also of Dz, are reversed by a 26 AA peptide consisting of the BH3-domain of Bad (BH3 peptide, known to have nM affinity for BclxL, but 1-2 orders less so for Bcl-2 (Kelekar et al, 1997; Petros et al, 2001) ). A single AA substitution in the BH3 peptide (L12A), that reduces the affinity for Bcl-xL by almost 2 orders of magnitude (Wang et al, 2000) , eliminated the inhibitory effects ( Figure 5C ). Notably, unlike BclxL, Bcl-2 has no effect on F1Fo H + and K + ion currents, which agrees with their known affinities for the BH3-domain of Bad, respectively. In binding experiments measuring changes in intrinsic tryptophan fluorescence, we found that Bcl-xL has a high affinity (sub-nM Kd) for the ligand IF1, whereas Bcl-2's affinity is several orders of magnitude lower (see Material and methods, section Protein binding (Kd) measurements). These data suggest that IF1 harbors a functionally-active BH3 domain homologous to that of Bad that overlaps with part of IF1's inhibitory domain and functions as the area of binding to the β-subunit of F1. Additionally, Bcl-xL and Mcl-1, but not Bcl-2, serve as endogenous regulatory ligands of ATP synthase via interaction with IF1 at the BH3-like domain.
Regulation of ATP synthase by Bcl-xL, Mcl-1 and Dz requires IF 1
Thus far, we have discussed the role and function of IF1 in intact cells, organelles and purified single molecules of F1Fo, as well as in IF1-knockdown experiments. Next, we examined the regulation of F1Fo by Bcl-xL, Mcl-1 and Dz in the absence of IF1, and upon reconstitution with IF1. We measured H + and K + currents in F1Fo isolated from IF1 -/-mice (see Figure 5D -figure supplement 1) regarding the IF1 -/-mice generation and confirmatory proof of lack of IF1 expression) and the baseline properties of the ionic currents were essentially similar to that of WT control. Importantly, upon reconstitution with IF1, PH and PK as well as total current reversal potential were found to be unchanged. One notable difference, however, was the ability of graded mM ATP amounts (by the energy transferred via its hydrolysis) to produce sufficient mechanical counter-torque (exerted by F1 on the γ shaft) in excess of the oppositely-directed electrogenic mechanical torque exerted by Fo, causing a net reversal of electrical current in the IF1 -/-case (resulting in ATP hydrolysis-generated reverse ion pumping). The latter (i.e., ATP-generated reverse ion pumping) was not observed in parallel experiments with WT and is entirely consistent with the known function of IF1 to limit the waste of futile ATP hydrolysis by impaired mitochondria under circumstances when ΔΨm would drop below levels needed to synthesize ATP (Walker, 1994) .
Assessing the current-time integral function (CTI, which in the direction of negative current is the direct analog of the amount of ATP synthesized) after reconstitution of F1Fo with IF1 in IF1 -/-, we observed a small increase of ~11-14% in CTI (vs baseline). Thus, it is notable that IF1 does not cause a net inhibitory drag on the energy transfer in F1Fo likely due to frictional losses in the direction of ATP synthesis (see also discussion below regarding BH3 peptide effects). In contrast to WT, neither Dz, Bcl-xL nor Mcl-1 exerted a significant positive augmentation of CTI in the absence of IF1, and subsequent IF1 reconstitution was similarly ineffective ( Figure 5D ). A likely explanation for the apparent ineffectiveness of IF1 added after Bcl-xL, Mcl-1 or Dz can be given by the possible interference exerted by these molecules on the intrinsic disorder of IF1 (Bason et al, 2014) , hindering its interaction at the F1's binding cleft and γ shaft into a functionally active complex. In one case, the 5-fold excess of IF1 used leaves effectively no free Bcl-xL because of the high affinity of this pair, and presumably only free IF1, rather than bound, is able to reconstitute F1Fo. In the case of Dz, this molecule could directly affect the intrinsic disorder of IF1 or the binding cleft preventing effective reconstitution. On the other hand, prior reconstitution of F1Fo with IF1 restores the WT behavior entirely, with Dz, Bcl-xL and Mcl-1 manifesting a robust augmentation of CTI. Taken together, these data allow us to conclude that IF1 is required for these mediators to augment F1Fo activity (for the same driving force).
As stated earlier, the positive effects of Bcl-xL and Mcl-1 on WT F1Fo currents could be reversed by the BH3 peptide (but not by the L12A variant, null-acting control BH3 peptide). Since this BH3 peptide, as well as IF1, likely binds to the same region of F1-β, but because of its short length is unable to reach to the γ shaft, we examined the functional effects upon binding F1Fo in the absence of IF1. We found that in IF1-deficient F1Fo, the BH3 peptide alone exerts a robust positive effect comparable to that of Dz, Bcl-xL and Mcl-1 (i.e., doubling to tripling the activity), but the L12A-modified BH3 peptide had no effect, suggesting that IF1 likely produces significant frictional drag via its constitutive contact with the γ shaft that is fully offset by some functionaugmenting mechanism achieved by the portion of IF1 bound to F1-β (see below and Discussion).
Regulation of mechano-chemical efficiency of F 1 F o
We have shown that F1Fo, conducting univalent cations at a fixed driving energy, Δμ, can be upregulated to increase the total ion flux against a constant load without slip or leak via the IF1-dependent actions of synthetic small molecules such as Dz and pinacidil, and endogenous proteins such as Bcl-xL and Mcl-1. The absence of slip is revealed by complete inhibition of currents at high Δμ by excess ATP. This activity enables ATP synthase to function as a recruitable mKATP, whereby the triggered increase of mitochondrial K + influx and matrix volume upregulate respiration and produce redox activation of local signaling inhibiting GSK-3β and resulting in desensitization of the mPTP to damaging levels of ROS (Juhaszova et al, 2004; Zorov et al, 2014) . . Dz and Bcl-xL produced a parallel upward shift of 5.6-fold in the F1Fo activity vs control ( Figure 6D ) indicating that the hydrolysis energy of an additional ~2.8 mM ATP is required to provide sufficient counter-torque to constrain the F1Fo to the same level of function as under control conditions. Based on considerations of energy conservation, the additional ATP synthesis might be driven by extra energy that was not lost to viscous drag and intermolecular friction. Together, these results are in agreement with the idea that Dz and Bcl-xL produced a parallel shift in the F 1 F o activity vs control resulting in the energy of an additional ~2.8 mM ATP being required to provide sufficient counter-torque to limit F 1 F o to the same level of function as under control conditions. The relative change in efficiency was calculated as the ratio of the free energy of ATP hydrolysis during activation by Dz and Bcl-xL over that under basal conditions. * P<0.05, ** P<0.02.
both Bcl-xL and Dz increase the mechano-chemical efficiency of ATP synthase (e.g., by ~7% at 1 mM, ~5% at 2 mM, and ~3% at 4 mM ambient ATP).
Discussion
Up to the present, it has been a central tenet of bioenergetics that mammalian ATP synthase operates solely on proton flux through Fo to make ATP. The present work significantly revises that concept. We found that in spite of the high degree of Fo's H (Mitchell, 1961) ; reviewed in (Nicholls & Ferguson, 2013) .
We demonstrated that purified F1Fo is utilizing up to 3.7 K + for every H + transferred. As such, the ATP synthase acts as a K + -uniporter, i.e., the primary way for K + to enter mitochondria; furthermore, since this K + entry is directly proportional to ATP synthesis and regulates matrix volume and respiration, in turn it serves the function of directing the matching of cellular energy utilization with its generation. Chemo-mechanical efficiency of ATP synthase can be up-regulated by certain members of the Bcl-2 family and by certain K + channel openers acting via an intrinsic regulatory factor of ATP synthase, IF1, in a process that increases the monovalent cation conductance of F1Fo while retaining its high degree H + -selectivity. The K + flux can be enhanced, halted, or even reversed depending on ATP concentration based on thermodynamic energy balance. Because of this, we found that ATP synthase is also a recruitable mKATP which serves critical functions in cell protection signaling. It can limit the damage of ischemia-reperfusion injury via redox activation of local signaling to desensitize the mPTP to damaging levels of ROS. The fundamental importance of these findings cannot be overstated since ATP synthase constitutes the main energy transduction mechanism in most living systems, including humans where it makes the daily equivalent of approximately the body's weight in ATP.
We show that F1Fo, conducting H , restoring Δμ K , is the way that the H + gradient energy is still the original, entire driving force for ATP production). However, the gain is that more ATP is produced for the same input energy by not wasting some of that energy on maintaining what was originally thought to be a separate K + cycle that does not/cannot generate any ATP. Engineered this way, it is a better, tightly coupled system of energy supply-demand matching through the K + cycle utilizing F 1 F o because the matrix influx of K + is truly directly proportional to ATP synthesis. Any transient increase in F 1 F o activity will thus lead to transient K + accumulation (due to a natural kinetic lag in the activity increase in KHE reacting to the matrix K + accumulation). This will lead to the attraction of a counter-ion and change of the osmotic drive yielding a "volume-activation of respiration" response which previously has been documented in detail (Juhaszova et al, 2004) . The scheme depicted in (C) integrates the implications of modestly enhancing the chemo-mechanical efficiency of and the counter-ion transport pathways are also important control steps in matrix volume regulation. Dysfunction of mitochondrial KHE activity leads to aberrations in matrix K + and mitochondrial volume regulation that in turn may affect fission/fusion and mitophagy. Such pathology is evident in the Wolf-Hirschhorn syndrome, a genetic insufficiency of mito-KHE activity (1/50,000 incidence, characterized by microcephaly, growth retardation, intellectual disability, and epileptic seizures among other severe manifestations (Zotova et al, 2010) ).
The K + uniporter function also enables F1Fo to operate as an on-demand, recruitable mKATP, whereby triggered increases of mitochondrial K + -influx and matrix-volume upregulate the signaling cascade resulting in desensitization of the mPTP, enhancing cell survival (Juhaszova et al, 2004) . Nature usually operates important pathways with built-in redundancy so that other mitochondrial K + channels may contribute to these mechanisms, including the Ca 2+ -activated K + channel, BKCa (Xu et al, 2002) , and a ROMK channel which may also mimic mKATP channel function (Foster et al, 2012) , but these pathways are likely fine-tuning mechanisms.
Our data also unveil that F1Fo operates at increased efficiency (by up to ~7% at normal ATP levels) in response to KCOs, Bcl-xL and Mcl-1, yielding both increased ATP output and matrix K + influx for the same ΔμH (Figures 6A-C; Figure 7C ). Dz and Bcl-xL cause a rightward shift in the ATP-dependence of the CTI (a quantitative index of ATP synthesis), such that the hydrolysis energy of an additional ~2.8 mM ATP is required to provide sufficient counter-torque to constrain the F1Fo to the same level of function as in controls. This means that an additional ~2.8 mM ATP can be produced for the same input energy at normal ambient levels of ATP. This provides quantitative proof that both Bcl-xL and Dz increase the mechano-chemical efficiency of F1Fo ( Figure 6D ). Recent work found that Bcl-xL interacts with the F1Fo (Alavian et al, 2011; Formentini et al, 2014) , specifically with the β-subunit of ATP synthase decreasing an ion leak within the F1Fo complex and concluded that this was responsible for increasing net transport of H + by F1Fo (Alavian et al, 2011) . These latter findings and conclusions are non-trivially different from our experiments: (1) we do not observe ion leak (or slip) at all, regulated or otherwise, in F1Fo in the presence or absence of Bcl-xL, i.e., Bcl-xL does not inhibit an ion leak that is not present in ATP synthase, and (2) the increase in ATP synthetic capacity in response to Bcl-xL is specifically due to an increase in mechano-chemical efficiency of ATP synthase per se, and not by changing an ion leak into useful energy. These findings lead us to conclude that essential mitochondrial homeostatic and pro-survival mechanisms result from a regulated IF1-mediated increase in chemomechanical efficiency of F1Fo conducting both K + and H + . Our results add a significant dimension to the known, and apparently diverse biological function sets of F1Fo. Additionally, it was proposed that a certain triggered rearrangement of F1Fo dimers is functionally responsible for other major biological functions such as the mitochondrial cristae arrangements (Strauss et al, 2008) and the formation of the mPTP (Giorgio et al, 2013) .
Our findings raise the question of how IF1 might control the activity of ATP synthase to engage physiologic/homeostatic and survival-promoting mechanisms. Overall, our data are consistent with a "minimal inhibitory domain" of IF1 (residues 14-47 in bovine IF1 (van Raaij et al, 1996) ) binding to the β-subunit of F1 in an "IF1 ligand-binding cleft" (adjacent to the F1 α-subunit interface), forming at its proximal end an α-helix loop that interacts with the F1 γ-rotor shaft which is responsible for limiting ATPase activity. With the evidence of a significant modulatory role by certain Bcl-2 members, we examined this domain for conserved survival protein-related homology domains. Bcl-xL and Mcl-1 are each known to have a BH3-binding groove with high affinity for certain domains of BH3. Together with the result of the high affinity binding of IF1 to Bcl-xL, our data is in agreement with IF1 harboring a functionally-active BH3-like domain homologous to that of Bad and coincident with IF1's inhibitory domain that functions as the binding patch to the β-subunit of F1. Binding of Bcl-xL and Mcl-1, but not Bcl-2, via IF1 interaction, endogenously regulate F1Fo activity. This may explain why the effects of Bcl-xL, Mcl-1, and Dz, are reversed by the BH3 peptide, but not by the same peptide with a single AA change (L12A) (Kelekar et al, 1997; Wang et al, 2000) ( Figure 5C ). Specifically, the BH3 peptide may compete and displace IF1 from its binding site on F1Fo, as well as interfere with its binding to Bcl-xL or Mcl-1. Moreover, we have shown that, unlike in WT, neither Dz nor Bcl-xL significantly increased CTI in F1Fo from (Sievers et al, 2011) and the tree and divergence times (in Myr) were calculated by MEGA 6.0 (for further details see Figure 8 -figure supplements 1-3, and Table 1 ).
IF1
-/-. Alternatively, prior reconstitution of F1Fo in the presence of IF1 entirely rescued the WT behavior, with both Dz and Bcl-xL strongly augmenting the ion currents. These data allow us to conclude that the higher ATP synthase activity elicited by these effectors (for the same driving force) requires IF1, and that the mere removal from its binding site does not suffice to enhance the enzyme activity. We propose that in the normal basal state IF1 has two mechanical and nearly offsetting effects on the function of ATP synthase operating in the synthesis direction: (1) a net negative, frictional drag-like effect of the IF1 molecule originating at its proximal end where it engages the γ shaft in its natural rotation, and (2) a net positive effect created somehow by the presence of the long α-helical stretch that engages the IF1 binding cleft on F1-β, the latter effect being mimicked by the BH3-peptide. It has been shown that Bcl-xL can interact forming 3D-domain swapped (3DDS) homodimers (O'Neill et al, 2006) as well as heterodimers with other survival-regulating proteins. These interactions can significantly affect the residual function of both partners (Rajan et al, 2015) , and certain BH3-only proteins can bind to and partially unfold Bcl-xL, changing its interactions with other binding partners and thereby biasing cell survivalsignaling (Follis et al, 2013) . Thus, our two-fold proposal implies that (1) Bcl-xL/Mcl-1 (via their intrinsic BH3-binding grooves) tightly bind to IF1 at its minimal inhibitory/BH3-like domain to displace it from its binding cleft at F1-β, and (2) this interaction triggers a specific unfolding and rearrangement of the Bcl protein's α2 helix, enabling an increase of its potential range-of-motion. This could allow the helix from the Bcl protein to participate in an energetically favorable rearrangement with F1Fo by binding to the empty IF1 binding cleft. We propose a possible model of this interaction (Bcl-protein's α2 helix containing its BH3 domain engaging the IF1 binding cleft on F1-β; Figure 8 ) that would cause the Bcl-xL/Mcl-1-mediated increase of F1Fo function in the presence of IF1, analogous to that obtained with the BH3 peptide added to the IF1 deficient F1Fo ( Figure 5D ). The mechanism by which a short IF1/BH3-(like) helical-peptide structure occupying the natural IF1 binding groove can enhance the chemo-mechanical efficiency of F1Fo is of considerable interest, but how it specifically works remains a matter of future study.
The origin of IF1 in relation to the evolution of F1Fo is also an interesting question. There are conserved "IF1 domains" that can be found embedded in a variety of larger proteins across Archaea, Bacteria, and Eukaryotes (Geer et al, 2002) , suggesting ancient origins for this domain. Although F1Fo exists in all major lifeforms, IF1 as a separate entity is only known to regulate synthase function in Eukaryotes. It is tempting to speculate that when the early bacterium became a mitochondrion as a functional organelle of the eukaryotic cell, some 2 billion years ago, it brought along the genetic information for IF1, which might have evolved to prevent the mitochondrion from wasteful ATP consumption in the host cell. We examined these bacterial IF1-progenitors and they have regions homologous to the BH3-like domains that we found in eukaryotic IF1's. The Bcl family is also ancient, some 2 billion years extant and resident in eukaryotic lifeforms. Phylogenetic analysis shows that IF1 is actually an ancient member of the Bcl family and today may be most closely related to BH3-containing proteins (e.g., Bad, PUMA, Bcl-xL; Figure 8E ; Figure 8 -figure supplements 1-3, Table 1 ). This may explain how the Bcl-2 protein family has come to regulate F1Fo function as part of its repertoire of survival-regulating functions.
In conclusion, we demonstrated that F1Fo utilizes the ion gradient energy not only of H + but also of K + to drive ATP synthesis. The essential mitochondrial homeostatic and pro-survival mechanisms discussed here, including F1Fo operation as a primary mitochondrial K + uniporter to facilitate energy supply-demand matching, and as a recruitable mKATP channel to protect from pathological opening of the mPTP, result from regulated function of ATP synthase conducting both K + and H + . The specific mechanisms by which KCOs and certain Bcl-2 family proteins engage IF1 to produce an increase in the chemo-mechanical efficiency of ATP synthase will require additional investigation.
Material and methods
Cell isolation.
Adult cardiac myocytes were isolated from Sprague-Dawley rats (2-4 months old), and WT or IF1 KO mice by using standard enzymatic techniques, as described previously (Capogrossi et al, 1986) . Isolated cardiomyocytes were suspended in a solution containing (in mM): NaCl 137, KCl 4.9, MgSO4 1.2, NaH2PO4 1.2, glucose 15, HEPES 20, and CaCl2 1.0 (pH 7.4). Handling of animals was conducted in accordance with NIH guidelines for animal care and use.
Immunocapture isolation/purification of intact F 1 F o from rat heart mitochondria, and the functional reconstitution into proteoliposomes (PL). All chemicals where from Sigma-Aldrich (St. Louis, MO), except where otherwise noted. Rat heart mitochondria were solubilized in 1% lauryl maltoside (LM; Anatrace Inc., Maumee, OH) or 1.5% -2% digitonin for 10 min, unsolubilized material was removed by centrifugation at 25000 x g for 15 min. F1Fo was immunocaptured using a Complex V immunocapture kit (MitoSciences Inc., Eugene, OR). Integrity and purity of the isolated F1Fo was determined by gel electrophoresis under native and denaturing conditions. NativePage Novex 3-12% Bis-Tris gel system (Invitrogen Corp., Carlsbad, CA) was applied to analyze samples under native clear and native blue (0.002% Coomassie Blue G-250) conditions. Gels were silver or Coomassie stained, or blotted to a PVDF membrane (GE Healthcare Bio-Sciences, Marlborough, MA) for protein immunodetection. Purified F1Fo was reconstituted into proteoliposomes using a modified procedure based on a method developed originally by (Paucek et al, 1992) . Briefly, for ATP measurements, cardiolipin and phosphatidylcholine in a 1:9 ratio were dried under nitrogen and dispersed at 100 mg/ml in an outwardly-directed potassium gradient was employed with an internal buffer containing (in mM): 10 NaH2PO4, 200 K2SO4 (or KCl; and Na2SO4 or NaCl), 0.25 EDTA, 20 HEPES, pH 7.0. Lipids were solubilized by octylpentaoxyethylene detergent. ~ 5 µg of isolated F1Fo was added to 10 mg of solubilized lipids. Proteoliposome (PL) formation was induced by removal of the detergent in Bio-beads SM2 column (Bio-Rad Laboratories, Hercules, CA).
Rat mitochondria and submitochondrial membrane particles isolation
Mitochondria were isolated by differential centrifugation of the heart homogenate. Fresh submitochondrial membrane particles (SMP) were made by sonicating rat heart mitochondria until cloudy preparation turns clear, then centrifugation at 16,000 x g for 15 minutes and subsequent centrifugation of the supernatant at 140,000 x g for 20 minutes to pellet the SMPs, which were resuspended in isolation medium. For electrophysiological measurements the isolated SMPs were added directly into the trans chamber.
Protein detection
BCA (bicinchoninic acid) protein assay (Pierce Biotechnology, Inc., Rockford, IL) was used for measurements of protein concentration.
Immunoblotting
For analysis under denaturing conditions, mitochondria or cells were lysed for 30 min on ice with RIPA buffer (0.15 mol/L NaCl, 10 mmol/L Tris (pH 7.4), 1 % NP-40, 0.1 % SDS, 0.5 % deoxycholate,1 mmol/L NaF, 1 mmol/L sodium orthovanadate) and protease inhibitors (Roche Diagnostics), and the lysates were centrifuged (25 min at 4°C; 25,000 x g). Lysates or purified F1Fo were heated (10 min at 75 ºC) in the NuPage LDS sample buffer under reducing conditions. Proteins extracts were separated using pre-cast NuPAGE Bis-Tris 4-12% gels (Invitrogen). Gels were then silver stained or the proteins were transferred to a PVDF membrane. The membranes were blocked with 5% nonfat dry milk in tris(hydroxymethyl)aminomethane (Tris)-buffered saline with 0.1% Tween 20 (TBST) and incubated overnight with primary antibodies; followed by horseradish peroxidase-linked secondary antibodies (Amersham Biosciences, Piscataway, NJ). Protein bands were visualized using ECL system (Amersham Biosciences) diluted in TBST. 
Immunofluorescence
Cultured neonatal cardiac myocytes were fixed with 2% formaldehyde in PBS (phosphate buffered saline; Sigma-Aldrich) followed by permeabilization with 0.5% Triton X-100/PBS. We blocked nonspecific cross reactivity by incubating the samples for 4 h in 1% BSA/PBS (Jackson ImmunoResearch, West Grove, PA, USA) and then performed cell immunolabeling via incubation with primary anti-IF1 antibody diluted in 1% BSA/PBS overnight, washing in PBS followed by appropriate fluorescence label-conjugated secondary antibodies (Jackson ImmunoResearch). Labeled cells were imaged by a Zeiss LSM-510 (Carl Zeiss, Jena, Germany) confocal microscope using a 63x/1.4 N.A. oil immersion lens.
ATP measurements
External buffer (EB) contained (in mM): 10 NaH2PO4, 200 TEA-SO4 (or TEA-Cl), 2.5 MgCl2, 0.090 ADP (ultra-pure; Cell Technology Inc., Mountain View, CA), 1 EDTA, 0.001 FCCP, 20 TEA-HEPES pH 7.0, and using a Vapro osmometer (Wescor, Inc., Logan, UT) the osmotic activity of the internal solution (K + =200 mEq) was matched to that of the EB (K + =0, TEA + =200 mEq) with an appropriate amount of mannitol. 5 µl of formed PL was resuspended in 495 µl of EB. After 5 min incubation at room temperature the ATP production was determined by luciferase/luciferin system using ATP bioluminescence assay kit HS II (Roche Diagnostics GmbH, Penzberg, Germany) in a Tropix TR 717 microplate luminometer (Bedford, MA).
To measure ATP production/consumption kinetics we developed a novel on-command acceleration-triggered inertial injector system, contained entirely inside individual wells of a 96 well plate, capable of accurately and reproducibly introducing and admixing 1-2 µL volumes in 1-5 sec (as desired, and without optical interference) during continuous chemiluminescence recording protocols. Specifically, individual wells of a 96 well plate were loaded with 198 µL of EB (see above) supplemented with 30 µM luciferin (Sigma-Aldrich) and 30 pmol/well of luciferase (Promega Corp., Madison, WI); a meniscus-stabilized microcarrier containing 1-2 µL of PL (loaded with internal 200 K + buffer) was carefully placed on top of the EB. After the background-level luminescence was acquired (Victor3 plate reader; PerkinElmer Inc.; Waltham, MA), the ATP generating system (PL) was injected into the buffer-containing well (which initiates the ATP synthesis reaction). This method enables measurement the relatively fast reaction kinetics of ATP synthesis (from microliter reaction quantities) from baseline to completion of the reaction. K + flux measurements A similar procedure as described above was used to prepare PLs for determination of K + fluxes; additionally, vesicles were loaded with the potassium sensitive probe PBFI (Invitrogen). Extravesicular PBFI was removed by passing the vesicles through 2 ml Bio-Spin columns (Bio-Rad Laboratories, Hercules, CA), which had been pre-equilibrated with internal buffer without the probe. In these experiments, an inwardly-directed potassium gradient was employed and the internal buffer contained (in mM): 125 TEA-SO4, 1 EDTA, 25 TEA-HEPES pH 7.0, and 0.3 PBFI. The osmotic activity of the internal solution (K + =0) was matched to that of the external buffer (K + =150 mEq) with an appropriate amount of mannitol, using an osmometer. 5 µl of suspension was transferred with vigorous stirring into a cuvette containing 495 µl: in mM 150 KCl, 1 EDTA, 25 HEPES, 1 µM FCCP, pH 7.0. PBFI-fluorescence ratio was measured continuously in a PerkinElmer LS 50B fluorescence spectrophotometer and the normalized initial rate of rise of the signal was taken as the index of K + influx.
In-gel ATPase assay
The in-gel ATPase assay described in (Wittig et al, 2006) was slightly modified: Clear native (CN) and blue native (BN)-gels were preincubated for 2 hr in 270 mM glycine, 35 mM Tris, pH 8.4. In a parallel assay, ATPase was inhibited with 5 µg/ml oligomycin. Gels were incubated for 45 min in ATPase reaction medium (in mM): 270 glycine, 35 Tris, 8 ATP, 14 MgSO4, 0.2% PbNO3, pH 8.4. Gels were washed with water and precipitated white lead phosphate bands were transformed to dark brown lead sulfide bands by immersion of the gels in 5% ammonium sulfide followed by a water rinse. Gels were then fixed (40% methanol, 10 % acetic acid) and protein visualized using a colloidal blue staining kit (Invitrogen).
Protein binding (K d ) measurements
For dissociation constant (Kd) measurements of IF1 to Bcl-2-family proteins (Bcl-2, Bcl-xL), 100 nM of Bcl-protein was admixed with 0-200 nM of IF1. Binding was monitored via changes in intrinsic Trp fluorescence, excited at 295 nm and fluorescence detected at 350 nm. Measurements were performed using a PTI (Photon Technology, Inc.) fluorimeter. Extracted intensities were fitted to a generalized binding equation:
where [Bt] is the total Bcl-protein concentration, [I] is the concentration of IF1, F0 and A are background fluorescence and a scaling factor, respectively.
Cell and proteoliposome treatment
The following compounds were applied (alone or in combination) to cells and PL during experimental measurements: 3 mM LiCl (Calbiochem Corp., San Diego, CA, USA); 2-4 µM Foinhibitor venturicidin B (VENT; A.G. Scientific, Inc., San Diego, CA). MgATP (at various concentrations as indicated); 10 nM Tyr-D-Ala-Gly-Phe-D-Leu (DADLE); 100 µM glibenclamide; 30 µM diazoxide (Dz); 50 µM pinacidil; 500 µM 5-hydroxydecanoate (5HD); 1 µM oligomycin, 0.4-0.6 mM DCCD, 1 µM valinomycin; 1 µM FCCP; 20-100 nM Bcl-2, Bcl-xl and Mcl-1 (Sigma-Aldrich); 2 µM Bcl-2 binding peptide (Bad BH3 peptide) and its negative control (Calbiochem). Hamden, CT)). Briefly, "black" lipid membranes were formed across a 200 μm aperture that separated the cis-and trans-compartments of a custom designed and fabricated chamber. The lipid ratio of phosphatidylcholine (PC) : phosphatidylethanolamine (PE) : cardiolipin (CL) was 4.5:4.5:1 by mass. Proteoliposomes were added to the trans chamber (simulating the cytosolic side) which was held at virtual ground and contained a solution composed of (in mM): 150 KCl, 20 Tris-HCl, 1 EGTA, 0.5 ADP, 10 PO4 3-(with 50 μM DTT, pH 7.2). Measurements were made after spontaneous vesicle fusion and protein incorporation into the lipid bilayer membrane had been achieved. Voltage was applied (Warner BC-535 Bilayer Clamp amplifier) to the cis chamber (simulating the mitochondrial matrix) with the same composition as the trans solution except having 50 mM KCl. Single channel currents were filtered by a low-pass 8-pole Bessel filter at a corner frequency of 2 kHz and digitized at a sampling rate of 50 kHz. All measurements were obtained at room temperature (22-23C).
Measurements of the mitochondrial volume in intact cells
Transmitted optics line-scan imaging to assess changes in mitochondrial volume in individual cardiomyocyte due to exposure to 30 µM DZ, 10 nM DADLE, 10 µM HOE with or without the Fo-inhibitor VENT. Changes in mitochondrial volume were assessed using a Zeiss 63x/1.4 N.A. oil immersion lens, 633 nm laser illumination, scanning 14.1 pixels/µm along the cell long axis for 72.6 or 145.1 µm). Fourier analysis (ImageJ, W. Rasband, NIH, Bethesda, MD) of repeating intensity of the linescan image provided the long-axis spacing of the sarcomere and mitochondrial compartments (from the 1st and 2nd order spectral peaks, enabling resolution of changes in dimension of ~1% in 1 µm structures). The position of the major Fourier spectral peak corresponding to ~1 µm spatial structures gives the average mitochondrial diameter, and the peakwidth gives an index of the variability about the mean (details of this procedure are described in (Juhaszova et al, 2004) ).
VO 2 measurements and flavoprotein fluorescence in intact cardiomyocytes
Cell respiration (VO2) was measured by the Clark-type O2 electrode based Mitocell S200 micro respirometry system (Strathkelvin Instruments Ltd. North Lanarkshire, UK). Oxidation of the flavoprotein (FP) pool is known to increase the blue light-excited cellular autofluorescence (Juhaszova et al, 2004; Sato et al, 1998) . Endogenous flavoprotein fluorescence was excited by an argon 488 nm laser line (attenuated to 1%) on a Zeiss LSM 510 using a 40x 1.3 NA oil objective. Emitted fluorescence was recorded at LP 505 nm. Relative fluorescence was calibrated to the values measured after 2,4-dinitrophenol (DNP) (fully oxidized) and cyanide exposure (fully reduced). Cells were continuously perfused (1-2 ml/min) and a time series of images was collected at intervals of 20 seconds. After baseline fluorescence was acquired (5 min), cells were exposed to diazoxide (10 min) and the experiment was completed by exposing the cells to DNP. Fluorescence traces from individual cell in the acquisition view were analyzed by MetaMorph image analysis software (Molecular Devices, Sunnyvale, CA) and then averaged.
Results are normalized to the dynamic range achieved in each cell when exposed to DNP, which by producing sufficient respiratory uncoupling, yields the maximum degree of autofluorescence change possible due to FP oxidation.
Mitochondrial swelling, membrane potential and K + flux determination in isolated mitochondria Mitochondria from guinea pig heart were isolated and assayed as described elsewhere (Aon et al, 2010) . Briefly, mitochondrial swelling, membrane potential (ΔΨm), and PBFI were monitored simultaneously with a spectrofluorimeter (Photon Technology, Inc.; Edison NJ) in an experimental solution containing (in mM): 250 sucrose (or 137 KCl), 0.5 EGTA, 2.5 MgCl2, 20 HEPES, 2 Pi, pH 7.2. Mitochondrial swelling was measured as a decrease in the 90° light scattering signal using 520 nm excitation. ΔΨm was recorded using 100 nM TMRM and quantified with a ratiometric method (Scaduto & Grotyohann, 1999) . PBFI fluorescence was monitored ratiometrically (340/380 nm excitation at 495 nm emission).
Determination of mitochondrial permeability transition threshold
We have previously developed and extensively tested a model enabling the precise determination of the mPTP sensitivity to oxidant stress in intact cardiac myocytes (Juhaszova et al, 2004; Zorov et al, 2000) . Briefly, small numbers of mitochondria inside isolated cardiomyocytes were exposed in situ to conditions of oxidative stress by repetitive (2 Hz) laser line-scanning (with imaging) of a single row of mitochondria in a cell loaded with 100 nM tetramethylrhodamine methyl ester (TMRM), using a Zeiss LSM-510 inverted confocal microscope. This results in incremental, additive exposure of only the laser-exposed area to the photodynamic production of ROS and consequent mPTP induction. The ROS-threshold for mPTP induction (tMPT) was measured as the average time necessary to induce the mPTP due to the local buildup of ROS in a row consisting of ~25 mitochondria.
Generation of IF1
-/-mice Mice carrying a genetically inactivated allele at the Atpif1 locus (C57BL/6NTac-Atpif1 tm1a(EUCOMM)Wtsi /WtsiCnbc), originally generated by the Wellcome Trust Sanger Institute for the EUCOMM project, within the International KnockOut Mouse Consortium (IKMC) (Bradley et al, 2012) , were obtained from the Spanish node of the European Mouse Mutant Archive (EMMA, http://www.infrafrontier.eu, mouse strain EM:05233) at the National Centre for Biotechnology in Madrid (Spain) and bred to homozygosity. Resulting homozygous mice are referred to as IF1 -/-in this manuscript. Mice were genotyped through a combination of separate PCR reactions that detect LacZ, the gene-specific wild type allele, and a mutant allele-specific short range PCR. For the phenotype verification of IF1 KO mouse see Figure 5D -figure supplement 1. Neonatal cardiac myocytes were isolated from 1-to 3-day-old Wistar rats by enzymatic digestion (Chesley et al, 2000) and cultured for two days before transfection with a pool of four short interfering RNAs (siRNAs; 100 nM) targeted specifically to IF1 using GeneSilencer reagent (Gene Therapy Systems Inc., San Diego, California, USA) according to the protocol provided by the company. Four siRNA duplexes were designed and synthesized by Dharmacon Inc. years when IF1 ancestor proteins separated from the ones that would originate BID, BIK and Bcl-2-like protein 13. The tree obtained from the Clustal Omega alignment (Figure 8 figure supplement 2) shows largely the same group division that has been considered elsewhere (Aouacheria et al, 2013) . In spite of our analysis being limited to only a fragment containing the BH3 motif, the same groups were obtained, i.e., BID-like, Bcl-2-like, also containing Bcl-xL (Lanave et al, 2004) , and a Bax-like (Aouacheria et al, 2013) . Additionally, an independent assessment of the alignment and phylogenetic analysis was performed with the program BAli-Phy (Figure 8-figure supplement 3 ). This rendered essentially a similar tree which mainly differed from the tree in Figure 8 -figure supplement 2 regarding the relative position of the Beclin and BAX groups (Figure 8-figure supplement 3 ). In our case there was no drift in the evolution of the hidden Markov Model (HMM) and the analysis of several Markov Chain Monte Carlo (MCMC) runs demonstrated convergence of the various chains toward a consensus alignment and phylogenetic tree. The main difference with the HMM described by Aouacheria (Aouacheria et al, 2013) is that longer fragments containing the so-called affinity enhancing motifs flanking the BH3 motif (Yang, 2010) were considered in the present work which renders the alignment more stringent.
Phylogenetic tree of the BH3 extended peptides Sequence Alignment and tree computation methods
The sequences aligned were obtained from the UniProt website (EMBL-EBI; http://www.uniprot.org). First, the BH3-containing proteins were obtained by performing a BLAST search of the BAD peptide (26 AA peptide used in our functional studies). A collection of 79 sequences of BH3 containing proteins was retrieved expanding from yeast to mammals including proteins from the BAD, BAK, BAX, BID, BIK, PUMA, MCL-1 and BECLIN groups. Then, a collection of 28 IF1 sequences, mostly manually annotated and reviewed, was gathered and aligned using Clustal Omega (http://www.clustal.org/omega). The fragments of the sequences obtained by this alignment were saved and used for subsequent analysis. These fragments correspond to 35 amino acids that contain the pattern of the original BAD peptide that was used as the seed. The unaligned peptides were used as input sequences for BAli-Phy (v 2.3.6 (Redelings & Suchard, 2005) ) a Linux program that uses Bayesian estimation and Markov Chain Monte Carlo (MCMC) methods to sample from the posterior distribution of alignments. Both alignments obtained from Clustal Omega and from BAli-Phy were utilized to construct the respective phylogenetic trees using the program MEGA 6.0 (Tamura et al, 2013) which allows computation of the the distances and the evolutionary times after linearization of the distances of divergence. For those calculations the reference point for the divergence between man and an ascomycete was 1540×10 6 ± 250 ×10 6 years (1540 Myr). The calculation of the tree was performed with the Neighbor Joining method (Saitou & Nei, 1987) .
Statistics
All experiments were performed at least in triplicate, with cell number greater than 12 in each independent experiment unless stated otherwise. All data are mean ± SEM. Comparisons within groups were made by an appropriate one-way ANOVA or Student t test, and P value ˂0.05 was considered as statistically significant.
